Overview

Harmonia Therapeutics is an oncology company developing DUET-ADCs™, a novel class of logic-gated antibody-drug conjugates. Our platform utilizes a dual-key mechanism requiring two signals to activate the drug exclusively inside cancer cells. By eliminating systemic toxicity, Harmonia aims to dramatically widen the therapeutic window for aggressive cancers.